EUGEEN MARIA JOZEF JANS,JENS JOZEF CEULEMANS,PHILIP ERNA H. HEYNS,TIM COSTELLO
申请号：
BR112015022753
公开号：
BR112015022753A2
申请日:
2014.03.10
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract of disclosure abuse deterrent solid dosage formulations containing 5 - ({[2-amino-3- (4-carbamoyl-2,6-dimethyl-phenyl) -propionyl] - [1- (4-phenyl-1h-imidazole-2 -yl) -ethyl] -amino} -methyl) -2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations. ___________________________________________________________________________________________ patent summary: dosage forms of opioid receptor modulators an abuse-proof solid dosage formulation containing 5 - ({[2-amino-3- (4-carbamoyl-2,6-dimethyl-phenyl) acid) -propionyl] - [1- (4-phenyl-1h-imidazol-2-yl) -ethyl] -amino} -methyl) -2-methoxybenzoic acid, and a process for the preparation and administration of such formulations.abstract of disclosure abuse deterrent solid dosage formulations containing 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, and processes for the preparation and administration of these formulations. ___________________________________________________________________________________ resumo patente de invenção: formulações de dosagens de moduladores de receptor opióide uma formulação de dosagem sólida à prova de abuso contendo o ácido 5-({[2-amino-3-(4-carbamoil-2,6-dimetil-fenil)-propionil]-[1-(4-phenil-1h-imidazol-2-il)-etil]-amino}-metil)-2-metoxibenzoico, e um processo para a preparação e administração dessas formulações.
